AT THE FOREFRONT OF THERAPIES FOR RARE DISEASES Q3 2025 Results Conference Call & Webcast November 4, 2025 Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 relating to the prospects and timing of the potential regulatory and pricing approval of our products, commercialization plans, manufacturing and supply plans, financing plans, the collaboration with Dimerix, and the projected revenues and cash po ...

Transforming Lives Through NeuroHealth COMPANY PRESENTATION NASDAQ: STIM November 2025 Forward Looking Statements This presentation contains estimates and other statistical data prepared by independent parties and by Neuronetics, Inc. ("Neuronetics" or the "Company") relating to market size and growth and other data about the industry in which the Company operates. These estimates and data involve a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates and d ...

业绩总结 - Broadridge在2026财年第一季度实现了977百万美元的经常性收入，同比增长9%[19] - 总收入为1589百万美元，同比增长12%[19] - 调整后的每股收益（EPS）为1.51美元，同比增长51%[19] - 调整后的营业收入为251百万美元，同比增长36%[19] - 关闭销售额为33百万美元，同比下降43%[19] 未来展望 - Broadridge预计2026财年经常性收入增长将在5-7%的指导范围的高端[12] - 调整后的EPS增长预期为8-12%[12] - 2026财年总销售额预期为2.9亿至3.3亿美元[48] - 2026财年调整后营业收入利润率预期为20%至21%（不考虑GAAP）[48] - 2026财年调整后每股收益增长率预期为8%-12%[83] 用户数据 - 2024财年投资者沟通解决方案的总持续收入为27.32亿美元，同比增长5%[50] - 2025财年总收入为68.89亿美元，同比增长12%[50] - 2024财年持续收入增长（GAAP）为9%[68] - 2025财年持续收入增长（GAAP）为7%[69] 财务健康 - Broadridge的自由现金流为13百万美元，自由现金流转化率为104%[41] - 2024财年每股分红为2.30美元，2026财年预期为3.90美元，年均增长约11%[46] - 2024财年总股息支付为2.48亿美元，股票回购为2.53亿美元[46] 业绩改善 - 2025财年第三季度的GAAP营业收入为188.8百万美元，较2024财年的134.4百万美元增长40.4%[70] - 2025财年第三季度的非GAAP调整后营业收入为251.2百万美元，较2024财年的184.8百万美元增长36.0%[70] - 2025财年第三季度的GAAP净现金流为42.3百万美元，较2024财年的-125.5百万美元显著改善[75] - 2025财年第三季度的非GAAP自由现金流为12.7百万美元，较2024财年的-157.6百万美元显著改善[75] - 2025财年第三季度的GAAP净收益为165.4百万美元，较2024财年的79.8百万美元增长106.0%[75] - 2025财年第三季度的非GAAP调整后净收益为178.1百万美元，较2024财年的118.3百万美元增长50.6%[75] 股票回购 - 公司在过去两个季度进行了2.5亿美元的股票回购[12]

Q3 2025 Financial Results & Business Update November 4 , 2025 Copyright © 2024 Harmony Biosciences. All rights reserved. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding our full year 2024 net product revenue, expectations for ...

Q3 2025 EARNINGS PRESENTATION NOVEMBER 4, 2025 SAFE HARBOR STATEMENT This presentation contains, and the conference call will contain, forward-looking statements under the Private Securities Litigation Reform Act safe harbor provisions. These statements, which include our expectations for spending in our industry and guidance for future financial performance, are based on management's current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause ...

• Substantially reduce debt levels • Invest in future growth • Reinstate a share repurchase program in the future SECOND QUARTER FISCAL 2026 HIGHLIGHTS 2Q Fiscal Year 2026 Earnings Presentation November 4, 2025 VERSACE SALE As previously announced, Capri Holdings entered into a definitive agreement to sell Versace to Prada for $1.375B in cash subject to certain adjustments. The transaction is expected to close in our fiscal third quarter, subject to customary closing conditions including regulatory approval ...

Net leverage ratio as of Q3 2025 was 3.8x Notes: Reconciliation of LTM Q3 Fiscal 2025 Net Loss and Debt Agreement Adjusted EBITDA 2 | | Three months | Nine months | Twelve | | | | --- | --- | --- | --- | --- | --- | | | ended | ended | months ended | | | | ($ thousands) | 28-Dec-24 | 27-Sep-25 | 27-Sep-25 | ($ thousands) | 27-Sep-25 | | Net (loss)/income | ($311,969) | $90,161 | ($221,808) | Total Debt | $2,214,380 | | Income tax expense | (58,985) | (7,487) | (66,472) | | | | Interest expense, net | 37,719 ...

业绩总结 - 第三季度营业收入为2.87亿美元，同比下降17.1%[11] - 第三季度净销售额为46.45亿美元，同比下降3.7%[11] - 第三季度毛利率为18.2%，较去年同期下降1.3个百分点[21] - 第三季度自由现金流预计为负1.81亿美元，同比增加1.59亿美元[11] - 2025年第三季度净销售额为133.63亿美元，同比下降4.1%[61] - 2025年第三季度的自由现金流为-13.65亿美元，同比下降90百万美元[61] - 2025年第三季度的每股收益为-7.62美元，较2024年同期的-0.13美元大幅下降[74] - 2025年前九个月的净销售额为13,363百万美元，较2024年同期的4,824百万美元增长[76] - 2025年前九个月的毛利为2,344百万美元，较2024年同期的942百万美元显著提升[76] 用户数据与市场表现 - 第三季度亚太地区的营业收入为5100万美元，同比下降18.9%[41] - 第三季度EMEA地区的营业收入为3000万美元，同比增长23.3%[37] - 第三季度美国市场的消费者原始设备市场份额连续第七个季度增长[10] - 预计2025年第四季度全球单位销量将下降约4%[45] - 2025年全年的消费者市场预期收缩幅度为-2%至0%[48] - 2025年全年的商业市场预期增长幅度为-2%至2%[48] 未来展望与战略 - Goodyear Forward计划预计2025年将增加约7.5亿美元的营业收入，2024年已实现4.8亿美元的收益[15] - 完成的资产剥离总收益约为22亿美元，显著降低了公司的杠杆率[10] - 截至2025年9月30日，第三方债务的计划偿还金额为5.6亿美元，预计将延长泛欧证券化计划的到期至2032年[85] 财务状况 - 2025年第三季度的总债务为80.56亿美元[71] - 2025年第三季度的净债务为66.86亿美元[71] - 2025年第三季度的库存为39.52亿美元[71] - 2025年前九个月的利息支出为341百万美元，较2024年同期的135百万美元增加[76] - 2025年第三季度的总资产减值费用为674百万美元，较2024年同期的125百万美元显著上升[74] - 2024年净债务为76.73亿美元，较上年上升约7%[82] 其他信息 - 2024年净收入为-2.7亿美元，较上年下降约141%[78] - 2024年每股收益为-0.09美元，较上年下降约18%[78] - 2024年自由现金流为-1.06亿美元，较上年改善[82]

Second Quarter 2025 Earnings Conference Call August 5, 2025 Proprietary business information of ADM. Proprietary business information of ADM. Proprietary business information of ADM. 2 Cautionary Note Regarding Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical or current fact included in this release, ...

DEC: The Only Publicly Traded Champion of the PDP Subsector Energy Third Quarter Financial & Operational Results Presentation November 4, 2025 Optimized The information contained in this document (the "Presentation") has been prepared by Diversified Energy Company PLC ("Diversified" or the "Company"). This Presentation is for general information purposes only and does not constitute an invitation or inducement to any person to engage in investment activity. While the information contained herein has been pr ...